Lipitas 5mg Tablet contains Rosuvastatin, a potent lipid-lowering agent belonging to the statin class of medications. It is primarily indicated for the treatment of hypercholesterolemia and mixed dyslipidemia to reduce elevated total cholesterol, low-density lipoprotein cholesterol (LDL-C), apolipoprotein B, and triglycerides, while increasing high-density lipoprotein cholesterol (HDL-C). Rosuvastatin acts by selectively inhibiting HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis, thereby decreasing cholesterol production in the liver and promoting increased clearance of LDL particles from the bloodstream. Lipitas 5mg is often prescribed as an adjunct to diet and lifestyle modifications, including exercise and weight control, to reduce the risk of cardiovascular events such as myocardial infarction, stroke, and the need for revascularization procedures in patients with established coronary artery disease or those at high risk. The 5mg dosage is typically used for patients requiring moderate lipid reduction or those initiating therapy with close monitoring for efficacy and tolerability. Common adverse effects may include headache, myalgia, and gastrointestinal disturbances; however, serious side effects such as myopathy and hepatotoxicity are rare but warrant regular clinical and laboratory assessment. Lipitas 5mg should be used cautiously in patients with hepatic impairment and contraindicated during pregnancy and lactation.

Dosage & How to Use